Clinical Trial Update: Valproic Acid Sodium Salt in Bipolar Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating valproic acid sodium salt for bipolar disorder has completed, sponsored by Sanofi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Valproic acid sodium salt (valproic acid sodium salt)

Snippet

Sponsor: Sanofi | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED